QRG Capital Management Inc. Trims Stock Position in Danaher Corporation $DHR

QRG Capital Management Inc. trimmed its stake in Danaher Corporation (NYSE:DHR) by 30.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,572 shares of the conglomerate’s stock after selling 13,553 shares during the period. QRG Capital Management Inc.’s holdings in Danaher were worth $6,260,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Sivia Capital Partners LLC boosted its holdings in shares of Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after buying an additional 119 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in Danaher by 1.8% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 210,828 shares of the conglomerate’s stock valued at $42,840,000 after acquiring an additional 3,659 shares during the period. NorthCrest Asset Manangement LLC boosted its stake in Danaher by 54.7% during the second quarter. NorthCrest Asset Manangement LLC now owns 1,978 shares of the conglomerate’s stock worth $402,000 after acquiring an additional 699 shares in the last quarter. Kingstone Capital Partners Texas LLC purchased a new stake in Danaher in the second quarter worth about $92,391,000. Finally, Assenagon Asset Management S.A. increased its stake in shares of Danaher by 4.5% during the second quarter. Assenagon Asset Management S.A. now owns 21,571 shares of the conglomerate’s stock valued at $4,261,000 after purchasing an additional 937 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of several recent research reports. KeyCorp reissued an “overweight” rating on shares of Danaher in a research report on Thursday, December 18th. TD Cowen upped their target price on shares of Danaher from $260.00 to $270.00 and gave the company a “buy” rating in a research note on Wednesday, January 7th. Jefferies Financial Group lifted their target price on shares of Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a research report on Wednesday, December 17th. Robert W. Baird set a $247.00 price target on Danaher in a research note on Wednesday, October 22nd. Finally, Redburn Partners set a $220.00 price target on shares of Danaher in a research report on Wednesday, October 8th. Twenty-one research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $252.83.

Insider Activity at Danaher

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of the business’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the transaction, the senior vice president owned 2,625 shares in the company, valued at $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Teri List sold 3,298 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. This trade represents a 13.71% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 30,248 shares of company stock worth $6,609,663. Company insiders own 11.10% of the company’s stock.

Danaher Trading Down 1.6%

Shares of DHR stock opened at $236.05 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $166.73 billion, a price-to-earnings ratio of 48.67, a price-to-earnings-growth ratio of 4.20 and a beta of 0.89. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $258.23. The stock’s 50-day moving average price is $228.31 and its 200-day moving average price is $211.93.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the business posted $1.71 earnings per share. Danaher’s quarterly revenue was up 4.4% on a year-over-year basis. Equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. Danaher’s payout ratio is currently 26.39%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.